Pharmacognosy and Natural Products

Dr. Bayer’s research is mainly applied in nature. The major activity is centered around fabrication and characterization of functional polymer nanocomposites. The Smart Materials Platform@IIT has a number of research activities on fabrication and characterization of electrically and magnetically functional polymer nanocomposites, preparation and characterization of biomaterial nanocomposites for antimicrobial applications and drug delivery, processing of novel cellulosic materials, new generation polymer blends and surface modification and functionalization. Dr. Bayer participates in these research activities by supervising or helping supervise a number of graduate students and post doctoral colleagues. Moreover, Dr. Bayer has ongoing collaborations with the Department of Mechanical and Industrial Engineering at the University of Illinois at Chicago and with the Department of Mechanical and Aerospace Engineering at the University of Virginia.

Polymer Nanocomposites Surface Science Super-wetting and super-repellent surfaces Biopolymer Processing Smart Materials Emulsion Science and Technology

Thomas Sanderson obtained his PhD at the age of 27 from the University of British Columbia, Vancouver, Canada and did postdoctoral studies at Michigan State University, USA. He is an associate professor at the INRS-Institut Armand-Frappier, Laval (Québec), Canada and has published more than 70 papers in reputed journals. His toxicology laboratory is focused on studying interactions of chemicals with steroidogenic enzymes in humans and wildlife and is currently funded by the Natural Sciences and Engineering Council (NSERC) of Canada and the Alternatives Research and Development Foundation (USA). Thomas is editorial board member of Toxicological Sciences and PeerJ.

Bhertha M. Tamura has completed her PhD at Clinical Hospital of the São Paulo’s Faculty of Medicine. Member of the American Academy of Dermatology, DASIL, IACD, Brazilian Society of Dermatology, Brazilian Society of Dermatologic Surgeons has published papers in reputed journals and has been serving as an editorial board member of repute besides being author of several book chapters and editor of cosmetic dermatology books.

Bhertha M. Tamura has completed her PhD at Clinical Hospital of the São Paulo’s Faculty of Medicine. Member of the American Academy of Dermatology, DASIL, IACD, Brazilian Society of Dermatology, Brazilian Society of Dermatologic Surgeons has published papers in reputed journals and has been serving as an editorial board member of repute besides being author of several book chapters and editor of cosmetic dermatology books.

Bhertha M. Tamura has completed her PhD at Clinical Hospital of the São Paulo’s Faculty of Medicine. Member of the American Academy of Dermatology, DASIL, IACD, Brazilian Society of Dermatology, Brazilian Society of Dermatologic Surgeons has published papers in reputed journals and has been serving as an editorial board member of repute besides being author of several book chapters and editor of cosmetic dermatology books.

POSITION TITLE: Research Professor, University of Iowa, Iowa City, IA; Emeritus Professor of Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY EDUCATION/TRAINING (Begin with baccalaureate or other initial professional education, such as nursing, include postdoctoral training and residency training if applicable. Add/delete rows as necessary.)

The aim and focus of my research for many years has been to develop more effective and selective therapies for cancer patients based on data generated in preclinical models, and translated from bench to bed side and vice versa. In the 1990s, my laboratory, in collaboration with clinical colleagues at RPCI, developed the weekly schedule of 5-fluorouracil in combination with leucovorin as standard therapy for the treatment of colorectal cancer. In recent years, this laboratory was the first to demonstrate that therapeutic doses and schedule of methylselenocysteine, and seleno-L-methionine are potent inhibitors of hypoxia-induced and constitutively expressed HIF-1α and HIF-2α and associated specific types of miRNAs and VEGF expressed in tumor cells. Pronounced and sustained inhibition of these specific biomarkers was associated with therapeutic synergy with anticancer drugs. On the basis of data generated, a Phase 1 and 2 clinical trials of seleno-L- methionine in sequential combination with axitinib are under clinical evaluation in patients with advanced clear cell renal cell carcinoma.

Dr. Yan graduated in 2001 in Physical Chemistry from University of Science and Technology of China (USTC), and now is a full professor of USTC. His research focuses on carbon materials for energy conversion and storage, biomass conversion and green chemistry, and biomaterials and biomedicine based on polymers. Dr. Yan has published over 160 papers and edited three books.

Nanomedicine, Intensive Care, Transfusiology.

Experience about the X-ray crystallographic analyses, EM analeses, and NMR analyses of proteins, organic compounds, and inorganic compoundes for more than 15 years Enough experience of evaluation of molecular state of medicines using DSC or X-ray powder diffraction analysis Evaluation using the X-ray analyses of metal materials Deep knowledge about the higher mathematics, ability to apply it to financial engineering Management various programming languages Ability to develop of the application and operating system Pharmacist license

Experience about the X-ray crystallographic analyses, EM analeses, and NMR analyses of proteins, organic compounds, and inorganic compoundes for more than 15 years Enough experience of evaluation of molecular state of medicines using DSC or X-ray powder diffraction analysis Evaluation using the X-ray analyses of metal materials Deep knowledge about the higher mathematics, ability to apply it to financial engineering Management various programming languages Ability to develop of the application and operating system Pharmacist license

Andrey Nikolaevych Belousov graduate from Kharkov Medical Institute in 1988. Doctor of Medicine degree on speciality - An¬esthesiology and Intensive Care since 2004. The title dissertation: “Extracorporal hemocorrection using magnet-controlled sorbent in intensive therapy of intoxication syndromes in patients with hepatopancreatoduodenales dis¬eases”. Author a new medecine products – nanotechnology preparations based on magnetite nanoparticles (Fe3O4) of the size 6-12 nm (www.nanolab.com.ua): the peroral form - Micromage-B (the biologically active additive officially registration in Ukraine); Magnet-controlled sorbent brand of MCS-B for extracorporal detoxication of biological liquids (officially registration in Ukraine and was allowed for medical practice); NanoBiocorrector for intravenous application – ICNB (intracorporal nanosorbent). A.N. Belousov is author new method of extracorporal hemocorrection using magnet-controlled sor¬bent (MCS-B). Author a new program for estimation degree the severity of the patient. Based on previously developed a universal analytical system of the physiological state of the body (PHUAS) by the author proposed a new automatic program objective assessment of the severity of the patient's condition. Overall, the program can improve health of the population in terms of underfunding by the rapid and objective examination of a large quantity of people. Early on, with the help of the developed program is made possible among surveyed identify risk groups in the severity of general condition, to determine the optimal and effective options for prevention and treatment, saving time and money for the survey, use the data to correlate them with various factors influence of the environment (ecology, nutrition, addictions, drug, vaccine, methods of intensive therapy, pharmacotherapy, etc.). The published more 180 scientific works on results application of nanotechnology preparation in experimental and practical medicine. He has got 7 patents for the invention, 21 collected scientific articles, 68 works in other publications and thesis of reports at international conferences and congresses, including 35 of them abroad (Rumania, Austria, Germany, Czech, Switzerland, Hungary, Denmark, Portugal, Italy, Canada, U.S.A., China, India, and others). Author of the scientific film which focuses on the elaboration of artificial liver device and the development of a new direction in medicine – Nanotechnology. Andrey Belousov was awarded Medical Diploma of Europe “An Honorary Scholar Europe” and R. Koch medal for the scientific achievements, development of a new direction in medicine and elaboration of new method of treatment by means preparations of nanotechnology in 2008. Member of the Ukrainian and Russian Society Nanotechnology. Assistant editor-in-chief of the journal Archives of Blood Transfusion & Disorders (ABTD). Crimson Publishers, LLC, New York, USA. Member of the Editorial Board Nanosensors and Nanomaterials Journal Oscine Group Pvt Ltd., Near Manyata Embassy, Bangalore-India. Member of the Editorial Board Journal of Anaesthesia and Preoperative Care. Delaware, USA. At now Andrey Belousov - the Head of Laboratory Applied Nanotechnologies in Ukraine, DM, Professor of Department Anesthesiology, Intensive Care, Transfusiology and Hematology Kharkov Medical Academy of Postgraduate Education.

Nanomedicine, Intensive Care, Transfusiology.

Dr. Narasimha Murthy is a professor of Pharmaceutics at University of Mississippi.

The primary focus of our research group is to develop noninvasive and minimally invasive drug delivery systems and technologies to deliver drugs across the biological barriers. Current research projects are aimed at developing patient compliant therapies for the treatment of chronic disorders such as cancer, neurological disorders, skin and nail diseases. We are also interested in investigating the plasma pharmacokinetics, dermatokinetics and brain distribution of novel therapeutic molecules